DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,372 filers reported holding DANAHER CORPORATION in Q1 2019. The put-call ratio across all filers is 1.02 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $8,713,000 | +19.9% | 32,467 | +0.5% | 2.25% | +4.9% |
Q1 2021 | $7,268,000 | +0.2% | 32,292 | -1.1% | 2.14% | -3.2% |
Q4 2020 | $7,254,000 | +1.1% | 32,656 | -2.0% | 2.21% | -16.6% |
Q3 2020 | $7,178,000 | +20.4% | 33,333 | -1.2% | 2.65% | +6.9% |
Q2 2020 | $5,964,000 | +30.6% | 33,727 | +2.2% | 2.48% | +2.7% |
Q1 2020 | $4,567,000 | -8.6% | 32,997 | +1.4% | 2.42% | +16.3% |
Q4 2019 | $4,994,000 | -34.7% | 32,537 | -38.6% | 2.08% | -38.7% |
Q3 2019 | $7,653,000 | -0.3% | 52,985 | -1.3% | 3.38% | +2.8% |
Q2 2019 | $7,673,000 | +6.0% | 53,685 | -2.1% | 3.29% | +8.4% |
Q1 2019 | $7,236,000 | +24.4% | 54,810 | -2.8% | 3.04% | +11.3% |
Q4 2018 | $5,816,000 | -5.0% | 56,397 | +0.1% | 2.73% | +9.9% |
Q3 2018 | $6,124,000 | +13.0% | 56,355 | +2.6% | 2.48% | +8.7% |
Q2 2018 | $5,419,000 | -0.8% | 54,910 | -1.6% | 2.28% | -2.0% |
Q1 2018 | $5,461,000 | +6.4% | 55,775 | +0.9% | 2.33% | +105.2% |
Q4 2017 | $5,132,000 | +8.6% | 55,295 | +0.4% | 1.14% | +3.0% |
Q3 2017 | $4,726,000 | – | 55,095 | – | 1.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |